Contenido

Síguenos en…

Síguenos en Facebook. Pulsando en este enlace estarás saliendo de hvn.es   Síguenos en Twitter. Pulsando en este enlace estarás saliendo de hvn.es

Síguenos en YouTube. Pulsando en este enlace estarás saliendo de hvn.es   Feed de noticias

Publicaciones

Publicaciones (2015/2018)

  • JA. Baeyens-Fernández, E. Molina-Portillo, M. Pollán, M. Rodríguez-Barranco, R. Del Moral, L. Arribas-Mir, E. Sánchez-Cantalejo Ramírez, MJ. Sánchez. Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based study.. BMC cancer. 2018 18(1): pp. 781 - 781. FI: 3.288 Q2 D5. (doi:10.1186/s12885-018-4682-1 PMID:30068302)
  • E. Elez, T. Quintanar, J. Bosch-Barrera, J. Corral, N. Lainez, V. Moreno, CA. Rodriguez, E. Gonzalez-Flores, A. Cervantes. The Medical Oncology resident mentor: situation and workload.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2018 (doi:10.1007/s12094-018-1923-3 PMID:30062521)
  • E. Aranda, P. García Alfonso, M. Benavides, A. Sánchez Ruiz, C. Guillén-Ponce, MJ. Safont, J. Alcaide, A. Gómez, R. López, JL. Manzano, M. Méndez Ureña, J. Sastre, F. Rivera, C. Grávalos, T. García, JI. Martín-Valadés, E. Falcó, M. Navalón, E. González Flores, A. Ma García Tapiador, A. Ma López Muñoz, E. Barrajón, M. Reboredo, P. García Teijido, A. Viudez, N. Cárdenas, E. Díaz-Rubio. First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.. European journal of cancer (Oxford, England : 1990). 2018 (doi:10.1016/j.ejca.2018.06.024 PMID:30054049)
  • E. Salamanca-Fernández, M. Rodriguez-Barranco, YL. Chang-Chan, D. Redondo-Sánchez, S. Domínguez-López, E. Bayo, D. Narankiewicz, J. Expósito, MJ. Sánchez. Thyroid Cancer Epidemiology in South Spain: a population-based time trend study.. Endocrine. 2018. FI: 3.179 Q2 D5. (doi:10.1007/s12020-018-1681-6 PMID:30043094)
  • Á. Caballero Romero, MT. Delgado Ureña, A. Salmerón García, MT. Megías Fernández, M. Librada Porriño-Bustamante, J. Cabeza Barrera. Extravasation accidents with liposomal/liposomal pegylated anthracyclines treated with dexrazoxane: an overview and outcomes.. Anti-cancer drugs. 2018 (doi:10.1097/CAD.0000000000000672 PMID:30036190)
  • F. Artacho-Cordón, MF. Fernández, H. Frederiksen, LM. Iribarne-Durán, I. Jiménez-Díaz, F. Vela-Soria, AM. Andersson, P. Martin-Olmedo, FM. Peinado, N. Olea, JP. Arrebola. Environmental phenols and parabens in adipose tissue from hospitalized adults in Southern Spain.. Environment international. 2018 119: pp. 203 - 211 (doi:10.1016/j.envint.2018.05.052 PMID:29980043)
  • AM. Martín, M. Hidalgo, R. Alvarez, V. Arrazubi, J. Martínez-Galán, M. Salgado, T. Macarulla, A. Carrato. From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer.. Journal of Cancer. 2018 9(11): pp. 1978 - 1988. FI: 3.249 Q2. (doi:10.7150/jca.23716 PMID:29896283)
  • C. Balaña, A. Estival, I. Teruel, M. Hardy-Werbin, J. Sepulveda, E. Pineda, M. Martinez-García, O. Gallego, R. Luque, M. Gil-Gil, C. Mesia, S. Del Barco, A. Herrero, A. Berrocal, P. Perez-Segura, R. De Las Penas, J. Marruecos, R. Fuentes, G. Reynes, JM. Velarde, A. Cardona, E. Verger, C. Panciroli, S. Villà. Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2018 (doi:10.1007/s12094-018-1883-7 PMID:29737461)
  • K. Doello, R. Ortiz, PJ. Alvarez, C. Melguizo, L. Cabeza, J. Prados. Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review.. Nutrition and cancer. 2018 70(4): pp. 569 - 578 (doi:10.1080/01635581.2018.1464347 PMID:29708445)
  • C. Jimenez-Luna, C. Torres, R. Ortiz, C. Dieguez, J. Martinez-Galan, C. Melguizo, JC. Prados, O. Caba. Proteomic biomarkers in body fluids associated with pancreatic cancer.. Oncotarget. 2018 9(23): pp. 16573 - 16587 (doi:10.18632/oncotarget.24654 PMID:29662668)
  • C. Pérez-Ramírez, M. Cañadas-Garre, A. Alnatsha, E. Villar, J. Valdivia-Bautista, MJ. Faus-Dáder, MÁ. Calleja-Hernández. Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients.. The pharmacogenomics journal. 2018 (doi:10.1038/s41397-018-0014-8 PMID:29662106)
  • R. Gálvez, C. Maire, I. Tovar, P. Vargas. Naloxegol to Treat Constipation in a Patient Taking Opioids for Cancer Pain: A Case Report.. A&A practice. 2018 (doi:10.1213/XAA.0000000000000726 PMID:29634552)
  • JP. Arrebola, A. Castaño, M. Esteban, M. Bartolomé, B. Pérez-Gómez, JJ. Ramos. Differential contribution of animal and vegetable food items on persistent organic pollutant serum concentrations in Spanish adults. Data from BIOAMBIENT.ES project.. The Science of the total environment. 2018 634: pp. 235 - 242 (doi:10.1016/j.scitotenv.2018.03.283 PMID:29627546)
  • J. Zugazagoitia, M. Biosca, J. Olivera, M. Eugenia Olmedo, M. Dómine, E. Nadal, J. Carlos Ruffinelli, N. Muñoz, A. María Luna, B. Hernández, M. Martínez, I. Gallego, E. Martínez de Castro, C. Font, V. Calvo, V. Martínez-Marín, J. Corral, E. Noguerón, R. Mondéjar, I. García Escobar, C. Salvador-Coloma, Ó. Juan, M. Sánchez Cánovas, J. Valdivia, MP. Ochoa, R. López Castro, B. Obispo, C. Pangua, M. Sereno, L. Fernández Franco, X. Mielgo, J. Calzas, A. Blasco, F. Aparisi, L. Chara, J. Francisco Grau, M. Soares, A. Gómez, V. Zenzola, M. García-Morillo, D. Cacho, A. Díaz-Serrano, C. Aguado, S. Ponce-Aix, J. Luis González-Larriba, AJ. Muñoz, D. Lora, L. Paz-Ares, A. Manzano. Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced-rearranged non-small-cell lung cancer.. The European respiratory journal. 2018 51(5) (doi:10.1183/13993003.02431-2017 PMID:29563169)
  • F. Vela-Soria, LM. Iribarne-Durán, V. Mustieles, I. Jiménez-Díaz, MF. Fernández, N. Olea. QuEChERS and ultra-high performance liquid chromatography-tandem mass spectrometry method for the determination of parabens and ultraviolet filters in human milk samples.. Journal of chromatography. A. 2018 1546: pp. 1 - 9 (doi:10.1016/j.chroma.2018.02.060 PMID:29525126)
  • F. Gálvez-Montosa, JM. Jurado, F. Almazan. Widespread rash in lung adenocarcinoma.. ESMO open. 2018 3(1): pp. e000295 - e000295 (doi:10.1136/esmoopen-2017-000295 PMID:29387479)
  • E. Arriola, R. García Gómez, P. Diz, M. Majem, M. Martínez Aguillo, J. Valdivia, A. Paredes, JM. Sánchez-Torres, S. Peralta Muñoz, I. Barneto, V. Gutierrez, JM. Andrade Santiago, F. Aparisi, D. Isla, S. Ponce, D. Vicente Baz, A. Artal, M. Amador, M. Provencio. Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.. BMC cancer. 2018 18(1): pp. 106 - 106. FI: 3.288 Q2. (doi:10.1186/s12885-018-4004-7 PMID:29382302)
  • L. Ruiz-López, I. Blancas, JM. Garrido, N. Mut-Salud, M. Moya-Jódar, A. Osuna, F. Rodríguez-Serrano. The Role of Exosomes on Colorectal Cancer: a Review.. Journal of gastroenterology and hepatology. 2018 33(4): pp. 792 - 799 (doi:10.1111/jgh.14049 PMID:29156509)
  • E. Adoamnei, J. Mendiola, F. Vela-Soria, MF. Fernández, N. Olea, N. Jørgensen, SH. Swan, AM. Torres-Cantero. Urinary bisphenol A concentrations are associated with reproductive parameters in young men.. Environmental research. 2018 161: pp. 122 - 128 (doi:10.1016/j.envres.2017.11.002 PMID:29156341)
  • A. Abad, E. Martínez-Balibrea, JM. Viéitez, VA. Orduña, P. García Alfonso, JL. Manzano, B. Massutí, M. Benavides, A. Carrato, M. Zanui, J. Gallego, C. Grávalos, V. Conde, M. Provencio, M. Valladares, R. Salazar, J. Sastre, C. Montagut, F. Rivera, E. Aranda. Genotype-based selection of treatment for patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial.. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 29(2): pp. 439 - 444. FI: 13.926 D1. (doi:10.1093/annonc/mdx737 PMID:29145602)
  • B. González-Alzaga, M. Lacasaña, AF. Hernández, JP. Arrebola, I. López-Flores, F. Artacho-Cordón, JP. Bonde, N. Olea, C. Aguilar-Garduño. Serum concentrations of organochlorine compounds and predictors of exposure in children living in agricultural communities from South-Eastern Spain.. Environmental pollution (Barking, Essex : 1987). 2018 237: pp. 685 - 694 (doi:10.1016/j.envpol.2017.10.109 PMID:29129429)
  • C. Rodríguez-Pérez, P. Vrhovnik, B. González-Alzaga, MF. Fernández, P. Martin-Olmedo, N. Olea, Ž. Fiket, G. Kniewald, JP. Arrebola. Socio-demographic, lifestyle, and dietary determinants of essential and possibly-essential trace element levels in adipose tissue from an adult cohort.. Environmental pollution (Barking, Essex : 1987). 2018 236: pp. 878 - 888 (doi:10.1016/j.envpol.2017.09.093 PMID:29021094)
  • MA. Díaz-Castellanos, KV. Gómez de Las Heras, T. Díaz-Redondo, E. González-Flores, V. Albiñana, LM. Botella. Case Report: Propranolol increases the therapeutic response to temozolomide in a patient with metastatic paraganglioma.. F1000Research. 2017 6: pp. 2087 - 2087 (doi:10.12688/f1000research.13185.1 PMID:29527294)
  • S. Martín Algarra, V. Soriano, L. Fernández-Morales, MÁ. Berciano-Guerrero, K. Mujika, JL. Manzano, T. Puértolas Hernández, A. Soria, D. Rodríguez-Abreu, E. Espinosa Arranz, J. Medina Martínez, I. Márquez-Rodas, J. Rubió-Casadevall, ME. Ortega, JM. Jurado García, MJ. Lecumberri Biurrun, I. Palacio, M. Rodríguez de la Borbolla Artacho, JP. Altozano, VE. Castellón Rubio, A. García, P. Luna, A. Ballesteros, O. Fernández, JA. López Martín, A. Berrocal, A. Arance. Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study.. Medicine. 2017 96(52): pp. e9523 - e9523 (doi:10.1097/MD.0000000000009523 PMID:29384960)
  • R. Gironés, I. Morilla, C. Guillen-Ponce, MD. Torregrosa, I. Paredero, E. Bustamante, S. Del Barco, G. Soler, B. Losada, L. Visa, E. Llabrés, B. Fox, JL. Firvida, R. Blanco, M. Antonio, F. Aparisi, M. Pi-Figueras, E. Gonzalez-Flores, MJ. Molina-Garrido, J. Saldaña. Geriatric oncology in Spain: survey results and analysis of the current situation.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 (doi:10.1007/s12094-017-1813-0 PMID:29327240)
  • C. Pérez-Ramírez, M. Cañadas-Garre, A. Alnatsha, E. Villar, JR. Delgado, MÁ. Calleja-Hernández, MJ. Faus-Dáder. Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer.. Pathology, research and practice. 2017 (doi:10.1016/j.prp.2017.11.015 PMID:29254785)
  • C. Freire, E. Amaya, F. Gil, MF. Fernández, M. Murcia, S. Llop, A. Andiarena, J. Aurrekoetxea, M. Bustamante, M. Guxens, E. Ezama, G. Fernández-Tardón, N. Olea. Prenatal co-exposure to neurotoxic metals and neurodevelopment in preschool children: The Environment and Childhood (INMA) Project.. The Science of the total environment. 2017 621: pp. 340 - 351 (doi:10.1016/j.scitotenv.2017.11.273 PMID:29190557)
  • P. Reclusa, S. Taverna, M. Pucci, E. Durendez, S. Calabuig, P. Manca, MJ. Serrano, L. Sober, P. Pauwels, A. Russo, C. Rolfo. Exosomes as diagnostic and predictive biomarkers in lung cancer.. Journal of thoracic disease. 2017 9(Suppl 13): pp. S1373 - S1382. FI: 1.804 Q4. (doi:10.21037/jtd.2017.10.67 PMID:29184676)
  • E. Adoamnei, J. Mendiola, M. Moñino-García, F. Vela-Soria, LM. Iribarne-Durán, MF. Fernández, N. Olea, N. Jørgensen, SH. Swan, AM. Torres-Cantero. Urinary concentrations of parabens and reproductive parameters in young men.. The Science of the total environment. 2017 621: pp. 201 - 209 (doi:10.1016/j.scitotenv.2017.11.256 PMID:29179076)
  • I. Blancas, M. Fontanillas, V. Conde, J. Lao, E. Martínez, MJ. Sotelo, A. Jaen, JL. Bayo, F. Carabantes, JJ. Illarramendi, MM. Gordon, J. Cruz, A. García-Palomo, C. Mendiola, E. Pérez-Ruiz, JS. Bofill, JM. Baena-Cañada, NM. Jáñez, G. Esquerdo, M. Ruiz-Borrego. Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 (doi:10.1007/s12094-017-1797-9 PMID:29178019)
  • M. Pastor, A. Lopez Pousa, E. Del Barco, P. Perez Segura, BG. Astorga, B. Castelo, T. Bonfill, J. Martinez Trufero, JJ. Grau, R. Mesia. SEOM clinical guideline in nasopharynx cancer (2017).. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 (doi:10.1007/s12094-017-1777-0 PMID:29098554)
  • M. Martínez-Garcia, J. Álvarez-Linera, C. Carrato, L. Ley, R. Luque, X. Maldonado, M. Martínez-Aguillo, LM. Navarro, MA. Vaz-Salgado, M. Gil-Gil. SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017).. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 (doi:10.1007/s12094-017-1763-6 PMID:29086250)
  • M. Perán, E. López-Ruiz, MÁ. García, S. Nadaraia-Hoke, R. Brandt, JA. Marchal, J. Kenyon. A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer.. Scientific reports. 2017 7(1): pp. 13998 - 13998. FI: 4.122 Q1 D2. (doi:10.1038/s41598-017-14571-x PMID:29070896)
  • I. Puche-Sanz, MJ. Alvarez-Cubero, M. Pascual-Geler, A. Rodríguez-Martínez, M. Delgado-Rodríguez, JL. García-Puche, J. Expósito, I. Robles-Fernández, C. Entrala-Bernal, JA. Lorente, JM. Cózar-Olmo, MJ. Serrano. A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs.. Oncotarget. 2017 8(41): pp. 70472 - 70480 (doi:10.18632/oncotarget.19718 PMID:29050295)
  • C. Pérez-Ramírez, M. Cañadas-Garre, A. Alnatsha, MÁ. Molina, AI. Robles, E. Villar, JR. Delgado, MJ. Faus-Dáder, MÁ. Calleja-Hernández. Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.. Surgical oncology. 2017 26(3): pp. 278 - 285. FI: 2.558 Q2 D5. (doi:10.1016/j.suronc.2017.05.004 PMID:28807247)
  • J. Capdevila, JM. Trigo, J. Aller, JL. Manzano, S. Garcia-Adrian, C. Zafon, O. Reig, U. Bohn, T. Ramon Y Cajal, M. Duran, B. Gonzalez-Astorga, A. Lopez-Alfonso, J. Medina, I. Porras, JJ. Reina, N. Palacios, E. Grande, E. Cillan, I. Matos, JJ. Grau. Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).. European journal of endocrinology. 2017 177(4): pp. 309 - 317 (doi:10.1530/EJE-17-0243 PMID:28687563)
  • N. Galiano-Castillo, M. Arroyo-Morales, M. Lozano-Lozano, C. Fernández-Lao, L. Martín-Martín, R. Del-Moral-Ávila, I. Cantarero-Villanueva. Effect of an Internet-based telehealth system on functional capacity and cognition in breast cancer survivors: a secondary analysis of a randomized controlled trial.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2017 25(11): pp. 3551 - 3559 (doi:10.1007/s00520-017-3782-9 PMID:28639097)
  • A. Carrato, A. Abad, B. Massuti, C. Grávalos, P. Escudero, F. Longo-Muñoz, JL. Manzano, A. Gómez, MJ. Safont, J. Gallego, B. García-Paredes, C. Pericay, R. Dueñas, F. Rivera, F. Losa, M. Valladares-Ayerbes, E. González, E. Aranda. First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD).. European journal of cancer (Oxford, England : 1990). 2017 81: pp. 191 - 202 (doi:10.1016/j.ejca.2017.04.024 PMID:28633089)
  • AJ. Muñoz Martín, J. Adeva, J. Martínez-Galán, JJ. Reina, M. Hidalgo. Pancreatic ductal adenocarcinoma: metastatic disease.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 19(12): pp. 1423 - 1429 (doi:10.1007/s12094-017-1690-6 PMID:28623515)
  • C. Guillén-Ponce, J. Blázquez, I. González, E. de-Madaria, J. Montáns, A. Carrato. Diagnosis and staging of pancreatic ductal adenocarcinoma.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 19(10): pp. 1205 - 1216 (doi:10.1007/s12094-017-1681-7 PMID:28612200)
  • JM. Sepúlveda-Sánchez, MÁ. Vaz, C. Balañá, M. Gil-Gil, G. Reynés, Ó. Gallego, M. Martínez-García, E. Vicente, M. Quindós, R. Luque, A. Ramos, Y. Ruano, P. Pérez-Segura, M. Benavides, P. Sánchez-Gómez, A. Hernández-Laín. Phase II trial of dacomitinib, a pan-HER (human epidermal growth factor receptor) tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.. Neuro-oncology. 2017 19(11): pp. 1522 - 1531 (doi:10.1093/neuonc/nox105 PMID:28575464)
  • MJ. Serrano, MJ. Alvarez-Cubero, D. De Miguel Pérez, A. Rodríguez-Martínez, L. Gonzalez-Herrera, I. Robles-Fernandez, JE. Hernandez, JLG. Puche, JA. Lorente. Significance of EGFR Expression in Circulating Tumor Cells.. Advances in experimental medicine and biology. 2017 994: pp. 285 - 296. FI: 1.76 Q3. (doi:10.1007/978-3-319-55947-6_16 PMID:28560681)
  • M. Mañós, J. Giralt, A. Rueda, J. Cabrera, J. Martinez-Trufero, J. Marruecos, A. Lopez-Pousa, JP. Rodrigo, B. Castelo, J. Martínez-Galán, F. Arias, M. Chaves, JJ. Herranz, V. Arrazubi, N. Baste, A. Castro, R. Mesía. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).. Oral oncology. 2017 70: pp. 58 - 64 (doi:10.1016/j.oraloncology.2017.04.004 PMID:28427761)
  • CI. Bayarri-Lara, D. de Miguel Pérez, A. Cueto Ladrón de Guevara, A. Rodriguez Fernández, JL. Puche, A. Sánchez-Palencia Ramos, J. Ruiz Zafra, CF. Giraldo Ospina, M. Delgado-Rodríguez, M. Expósito Ruiz, MJ. Moyano Rodriguez, JA. Lorente, MJ. Serrano. Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers†.. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2017 52(1): pp. 55 - 62 D3. (doi:10.1093/ejcts/ezx049 PMID:28369376)
  • N. Mendoza, F. Molero, F. Criado, MJ. Cornellana, E. González. Sexual health after breast cancer: Recommendations from the Spanish Menopause Society, Federación Española de Sociedades de Sexología, Sociedad Española de Médicos de Atención Primaria and Sociedad Española de Oncología Médica.. Maturitas. 2017 105: pp. 126 - 131 (doi:10.1016/j.maturitas.2017.02.010 PMID:28268037)
  • JM. Cejalvo, E. Martínez de Dueñas, P. Galván, S. García-Recio, O. Burgués Gasión, L. Paré, S. Antolín, R. Martinello, I. Blancas, B. Adamo, Á. Guerrero-Zotano, M. Muñoz, P. Nucíforo, M. Vidal, RM. Pérez, JI. Chacón López-Muniz, R. Caballero, V. Peg, E. Carrasco, F. Rojo, CM. Perou, J. Cortés, V. Adamo, J. Albanell, RR. Gomis, A. Lluch, A. Prat. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.. Cancer research. 2017 77(9): pp. 2213 - 2221 (doi:10.1158/0008-5472.CAN-16-2717 PMID:28249905)
  • A. Irigoyen, J. Gallego, C. Guillén Ponce, R. Vera, V. Iranzo, I. Ales, S. Arévalo, A. Pisa, M. Martín, A. Salud, E. Falcó, A. Sáenz, JL. Manzano Mozo, G. Pulido, J. Martínez Galán, R. Pazo-Cid, F. Rivera, T. García García, O. Serra, EM. Fernández Parra, A. Hurtado, MJ. Gómez Reina, LJ. López Gomez, E. Martínez Ortega, M. Benavides, E. Aranda. Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.. European journal of cancer (Oxford, England : 1990). 2017 75: pp. 73 - 82 (doi:10.1016/j.ejca.2016.12.032 PMID:28222309)
  • C. Morata-Tarifa, M. Picon-Ruiz, C. Griñan-Lison, H. Boulaiz, M. Perán, . , JA. Marchal. Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity.. Scientific reports. 2017 7: pp. 39782 - 39782. FI: 4.122 Q1. (doi:10.1038/srep39782 PMID:28051134)
  • R. Mesía, JA. Garcia-Saenz, A. Lozano, M. Pastor, JJ. Grau, J. Martínez-Trufero, J. Lambeaz, J. Martínez-Galán, JR. Mel, B. González, S. Vázquez, M. Mañós, M. Taberna, B. Cirauqui, ED. Barco, E. Casado, J. Rubió-Casadevall, A. Rodríguez-Jaráiz, JJ. Cruz. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group . International journal of radiation oncology, biology, physics. 2017 97(3): pp. 473 - 480 (doi:10.1016/j.ijrobp.2016.11.016 PMID:28011050)
  • J. Capellades, P. Teixidor, G. Villalba, C. Hostalot, G. Plans, R. Armengol, S. Medrano, A. Estival, R. Luque, S. Gonzalez, M. Gil-Gil, S. Villa, J. Sepulveda, JJ. García-Mosquera, C. Balana. Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 19(6): pp. 727 - 734 (doi:10.1007/s12094-016-1598-6 PMID:28005261)
  • M. Hidalgo, R. Álvarez, J. Gallego, C. Guillén-Ponce, B. Laquente, T. Macarulla, A. Muñoz, M. Salgado, R. Vera, J. Adeva, I. Alés, S. Arévalo, J. Blázquez, A. Calsina, A. Carmona, E. de Madaria, R. Díaz, L. Díez, T. Fernández, BG. de Paredes, ME. Gallardo, I. González, O. Hernando, P. Jiménez, A. López, C. López, F. López-Ríos, E. Martín, J. Martínez, A. Martínez, J. Montans, R. Pazo, JC. Plaza, I. Peiró, JJ. Reina, A. Sanjuanbenito, R. Yaya, A. Carrato. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 19(6): pp. 667 - 681 (doi:10.1007/s12094-016-1594-x PMID:27995549)
  • FF. Pérez, J. Lavernia, D. Aguiar-Bujanda, J. Miramón, J. Gumá, R. Álvarez, J. Gómez-Codina, FG. Arroyo, M. Llanos, M. Marin, J. Alfaro, C. Quero, M. Delgado, E. Nogales, F. Menarguez, N. Martinez, M. Torrente, A. Royuela, D. Abreu, M. Provencio. Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group.. Clinical lymphoma, myeloma & leukemia. 2017 17(3): pp. 186 - 191 (doi:10.1016/j.clml.2016.09.004 PMID:27847267)
  • M. Martin Jimenez, A. Calvo Ferrandiz, J. Aparicio Urtasun, R. Garcia-Campelo, E. Gonzalez-Flores, M. Lazaro Quintela, M. Muñoz Mateu, CA. Rodriguez Sanchez, A. Santaballa Bertran, JM. Sepulveda Sanchez, R. Vera Garcia, JA. Virizuela Echaburu, MA. Segui Palmer. New clinical trials regulation in Spain: analysis of royal decree 1090/2015.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 19(3): pp. 291 - 300 (doi:10.1007/s12094-016-1550-9 PMID:27718157)
  • R. García-Carbonero, R. Vera, F. Rivera, E. Parlorio, M. Pagés, E. González-Flores, C. Fernández-Martos, MÁ. Corral, R. Bouzas, F. Matute. SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 19(2): pp. 135 - 148 (doi:10.1007/s12094-016-1518-9 PMID:27206566)
  • MB G-O. Garcia-Ortega, GJL. Lopez, GJ. Jimenez, JAGG. García-García, VC. Conde, HB. Boulaiz, EC. Carrillo, MP. Perán, JAM. Marchal, MAGCH. García-Chaves. Clinical and therapeutic potential of protein kinase PKR in cancer and metabolism.. Expert reviews in molecular medicine. 2017 19(9): pp. 1-13. FI: 3.865 Q2 D3.
  • . . Human adipose tissue levels of persistent organic pollutans and metabolic syndrome components: combining a cross-sectional with a 10-year longitudinal study using a multipollutant approach. Environment International. 2017 104: pp. 48-57. FI: 7.297 Q1 D1.
  • E. González-Flores, F. Losa, C. Pericay, E. Polo, S. Roselló, MJ. Safont, R. Vera, J. Aparicio, MT. Cano, C. Fernández-Martos. SEOM Clinical Guideline of localized rectal cancer (2016).. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016 18(12): pp. 1163 - 1171. FI: 2.075 Q3. (doi:10.1007/s12094-016-1591-0 PMID:27905053)
  • J. Alcaide, M. Delgado, M. Legerén, JM. Jurado, I. Blancas, T. Pereda, J. López, M. Garrido, MJ. Sánchez, JL. García, A. Rueda. Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five cases.. Oncology letters. 2016 12(5): pp. 3127 - 3134. FI: 1.482 Q4. (doi:10.3892/ol.2016.5068 PMID:27899972)
  • R. Vera, E. Dotor, J. Feliu, E. González, B. Laquente, T. Macarulla, E. Martínez, J. Maurel, M. Salgado, JL. Manzano. SEOM Clinical Guideline for the treatment of pancreatic cancer (2016).. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016 18(12): pp. 1172 - 1178. FI: 2.075 Q3. (doi:10.1007/s12094-016-1586-x PMID:27896637)
  • E. Del Barco Morillo, R. Mesía, JC. Adansa Klain, S. Vázquez Fernández, J. Martínez-Galán, M. Pastor Borgoñon, C. González-Rivas, J. Caballero Daroqui, A. Berrocal, J. Martínez-Trufero, R. Vera, JJ. Cruz-Hernández. Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study.. Oral oncology. 2016 62: pp. 54 - 59. FI: 4.286 Q1. (doi:10.1016/j.oraloncology.2016.09.009 PMID:27865372)
  • D. Molina, J. Pérez-Beteta, A. Martínez-González, JM. Sepúlveda, S. Peralta, MJ. Gil-Gil, G. Reynes, A. Herrero, R. De Las Peñas, R. Luque, J. Capellades, C. Balaña, VM. Pérez-García. Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.. PloS one. 2016 11(8): pp. e0161484 - e0161484. FI: 3.057 Q1. (doi:10.1371/journal.pone.0161484 PMID:27557121)
  • C. Pérez-Ramírez, M. Cañadas-Garre, A. Alnatsha, E. Villar, JR. Delgado, MJ. Faus-Dáder, MÁ. Calleja-Hernández. PHARMACOGENETIC PREDICTORS OF TOXICITY TO PLATINUM BASED CHEMOTHERAPY IN NON-SMALL CELL LUNG CANCER PATIENTS.. Pharmacological research. 2016 111: pp. 877 - 884. FI: 4.816 Q1. (doi:10.1016/j.phrs.2016.08.002 PMID:27498158)
  • C. Fernández-López, J. Expósito-Hernández, JP. Arrebola-Moreno, MÁ. Calleja-Hernández, M. Expósito-Ruíz, R. Guerrero-Tejada, I. Linares, J. Cabeza-Barrera. Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer.. Cancer medicine. 2016 5(9): pp. 2190 - 2197. FI: 2.915 Q3. (doi:10.1002/cam4.782 PMID:27449070)
  • E. López-Ruiz, G. Jiménez, MÁ. García, C. Antich, H. Boulaiz, JA. Marchal, M. Perán. Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what's new?. Expert opinion on therapeutic patents. 2016 26(8): pp. 877 - 890. FI: 4.626 Q1. (doi:10.1080/13543776.2016.1203903 PMID:27337937)
  • N. Galiano-Castillo, I. Cantarero-Villanueva, C. Fernández-Lao, A. Ariza-García, L. Díaz-Rodríguez, R. Del-Moral-Ávila, M. Arroyo-Morales. Telehealth system: A randomized controlled trial evaluating the impact of an internet-based exercise intervention on quality of life, pain, muscle strength, and fatigue in breast cancer survivors.. Cancer. 2016 122(20): pp. 3166 - 3174. FI: 5.649 Q1. (doi:10.1002/cncr.30172 PMID:27332968)
  • MdelM. Alfaya Góngora, MJ. Bueno Pernias, C. Hueso Montoro, P. Guardia Mancilla, R. Montoya Juárez, MP. García Caro. Palliative care team visits. Qualitative study through participant observation.. Colombia medica (Cali, Colombia). 2016 47(1): pp. 38 - 44. FI: 0.873 Q3. ( PMID:27226663)
  • JP. Arrebola, M. Fernández-Rodríguez, F. Artacho-Cordón, C. Garde, F. Perez-Carrascosa, I. Linares, I. Tovar, B. González-Alzaga, J. Expósito, P. Torne, MF. Fernández, N. Olea. Associations of persistent organic pollutants in serum and adipose tissue with breast cancer prognostic markers.. The Science of the total environment. 2016 566-567: pp. 41 - 49. FI: 3.976 Q1. (doi:10.1016/j.scitotenv.2016.04.188 PMID:27213669)
  • J. González-Moreno, I. Losada-López, C. Gállego-Lezaun, M. García-Gasalla, C. Gómez Bellvert, N. Ortego Centeno. Serosal involvement in IgG4-related disease: report of two cases and review of the literature.. Rheumatology international. 2016 36(7): pp. 1033 - 1041. FI: 1.702 Q3. (doi:10.1007/s00296-016-3501-8 PMID:27207156)
  • I. Linares, J. Expósito, JP. Arrebola, J. Sánchez-Cantalejo, YL. Chang-Chan, E. Molina, R. Guerrero, MJ. Sánchez. 33P Prognostic factors associated with lung cancer survival. A population-based study in the South of Spain.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016 11(4 Suppl): pp. S69 - S69. FI: 5.04 Q1. (doi:10.1016/S1556-0864(16)30147-2 PMID:27198389)
  • A. Madrid-Paredes, M. Cañadas-Garre, A. Sánchez-Pozo, AM. Segura-Pérez, CC. Santos, EV. Alcaide, LC. Portellano, MÁ. Calleja-Hernández. ABCB1 C3435T GENE POLYMORPHISM AS A POTENTIAL BIOMARKER OF CLINICAL OUTCOMES IN HER2-POSITIVE BREAST CANCER PATIENTS.. Pharmacological research. 2016 108: pp. 111 - 118. FI: 4.816 Q1. (doi:10.1016/j.phrs.2016.04.016 PMID:27137881)
  • I. Jiménez-Díaz, F. Artacho-Cordón, F. Vela-Soria, H. Belhassen, JP. Arrebola, MF. Fernández, R. Ghali, A. Hedhili, N. Olea. Urinary levels of bisphenol A, benzophenones and parabens in Tunisian women: A pilot study.. The Science of the total environment. 2016 562: pp. 81 - 88. FI: 3.976 Q1. (doi:10.1016/j.scitotenv.2016.03.203 PMID:27096629)
  • I. Duran, C. Hagen, JÁ. Arranz, M. Apellaniz-Ruiz, B. Pérez-Valderrama, N. Sala, N. Lainez, X. García-Del Muro, E. Noguerón, MÁ. Climent, P. Maroto, A. Font, J. García-Donas, E. Gallardo, P. López-Criado, A. González Del Alba, MI. Sáez, S. Vázquez, R. Luque, C. Rodríguez-Antona. SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma.. Pharmacogenomics. 2016 17(5): pp. 463 - 471. FI: 2.71 Q2. (doi:10.2217/pgs.15.186 PMID:27020167)
  • C. Bayarri-Lara, FG. Ortega, A. Cueto Ladrón de Guevara, JL. Puche, J. Ruiz Zafra, D. de Miguel-Pérez, AS. Ramos, CF. Giraldo-Ospina, JA. Navajas Gómez, M. Delgado-Rodriguez, JA. Lorente, MJ. Serrano. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.. PloS one. 2016 11(2): pp. e0148659 - e0148659. FI: 3.057 Q1. (doi:10.1371/journal.pone.0148659 PMID:26913536)
  • C. Balana, R. De Las Penas, JM. Sepúlveda, MJ. Gil-Gil, R. Luque, O. Gallego, C. Carrato, C. Sanz, G. Reynes, A. Herrero, JL. Ramirez, P. Pérez-Segura, A. Berrocal, JM. Vieitez, A. Garcia, S. Vazquez-Estevez, S. Peralta, I. Fernandez, I. Henriquez, M. Martinez-Garcia, JJ. De la Cruz, J. Capellades, P. Giner, S. Villà. Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.. Journal of neuro-oncology. 2016 127(3): pp. 569 - 579. FI: 2.754 Q2. (doi:10.1007/s11060-016-2065-5 PMID:26847813)
  • R. Mesía, S. Vázquez, JJ. Grau, JA. García-Sáenz, A. Lozano, C. García, J. Carles, A. Irigoyen, M. Mañós, B. García-Paredes, E. Del Barco, M. Taberna, Y. Escobar, JJ. Cruz. A Phase 2 Open Label, Single-arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.. International journal of radiation oncology, biology, physics. 2016 94(2): pp. 289 - 296. FI: 4.495 Q1. (doi:10.1016/j.ijrobp.2015.10.019 PMID:26675064)
  • B. Pérez-Valderrama, JA. Arranz Arija, A. Rodríguez Sánchez, A. Pinto Marín, P. Borrega García, DE. Castellano Gaunas, G. Rubio Romero, C. Maximiano Alonso, JC. Villa Guzmán, JL. Puertas Álvarez, I. Chirivella González, MJ. Méndez Vidal, MJ. Juan Fita, L. León-Mateos, M. Lázaro Quintela, R. García Domínguez, JM. Jurado García, E. Vélez de Mendizábal, JJ. Lambea Sorrosal, I. García Carbonero, A. González Del Alba, C. Suárez Rodríguez, P. Jiménez Gallego, JA. Meana García, RD. García Marrero, P. Gajate Borau, C. Santander Lobera, C. Molins Palau, M. López Brea, EM. Fernández Parra, O. Reig Torras, L. Basterretxea Badiola, S. Vázquez Estévez, JL. González Larriba. Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: The Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.. Annals of oncology : official journal of the European Society for Medical Oncology. 2016 27(4): pp. 706 - 711. FI: 9.269 Q1. (doi:10.1093/annonc/mdv601 PMID:26658889)
  • MF. Fernández, JP. Arrebola, I. Jiménez-Díaz, JM. Sáenz, JM. Molina-Molina, O. Ballesteros, A. Kortenkamp, N. Olea. Bisphenol A and other phenols in human placenta from children with cryptorchidism or hypospadias.. Reproductive toxicology (Elmsford, N.Y.). 2016 59: pp. 89 - 95. FI: 2.85 Q2. (doi:10.1016/j.reprotox.2015.11.002 PMID:26602963)
  • C. Torres, A. Linares, MJ. Alejandre, RJ. Palomino-Morales, JR. Delgado, S. Perales. Interplay Between Gemcitabine and Erlotinib Over Pancreatic Adenocarcinoma Cells.. Pancreas. 2016 45(2): pp. 269 - 280. FI: 2.738 Q2 4. (doi:10.1097/MPA.0000000000000452 PMID:26495790)
  • I. Linares, MI. Tovar, M. Zurita, R. Guerrero, M. Expósito, RD. Moral. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.. Clinical breast cancer. 2016 16(4): pp. 262 - 268. FI: 3.082 Q2 15. (doi:10.1016/j.clbc.2015.09.012 PMID:26454613)
  • I. Linares, E. Molina-Portillo, J. Expósito, JA. Baeyens, C. Suárez, MJ. Sánchez. Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based study.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016 18(5): pp. 489 - 496. FI: 2.075 Q3. (doi:10.1007/s12094-015-1392-x PMID:26329296)
  • AJ. Conde-Moreno, JL. Lopez-Guerra, VA. Macias, ML. Vázquez de la Torre, P. Samper Ots, S. San José-Maderuelo, J. Pastor Peidro, J. López-Torrecilla, J. Expósito-Hernández. Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016 18(4): pp. 342 - 351. FI: 2.075 Q3. (doi:10.1007/s12094-015-1383-y PMID:26329294)
  • I. Tovar Martín, R. Del Moral Ávila, M. Zurita Herrera, G. Arregui, JL. Osorio-Ceballos, E. Saura Rojas, Á. Horcajadas Almansa, JP. Arrebola, J. Pastor Rull, J. Expósito Hernández, E. López Ramírez. The role of radiosurgery in the management of glomus tumours.. Head & neck. 2016 38(S1): pp. E798 - 804. FI: 2.76 Q1 1. (doi:10.1002/hed.24103 PMID:25914332)
  • MJ. Alvarez-Cubero, F. Vázquez-Alonso, I. Puche-Sanz, FG. Ortega, M. Martin-Prieto, JL. Garcia-Puche, M. Pascual-Geler, JA. Lorente, JM. Cozar-Olmo, MJ. Serrano-Fernández. Dormant Circulating Tumor Cells In Prostate Cancer: Biological, Clinical And Therapeutic Implications.. Current drug targets. 2016 1(1). FI: 3.029 Q2 6. ( PMID:25751007)
  • E. Almagro, CS. González, E. Espinosa. Prognostic factors of early breast cancer.. Medicina clinica. 2016 146(4): pp. 167 - 171. FI: 1.267 Q2 9. (doi:10.1016/j.medcli.2014.12.019 PMID:25726309)
  • J. Expósito, I. Linares, I. Castillo, M. Martínez, P. Vargas, I. Herruzo, JA. Medina, A. Palacios, E. Bayo, F. Peracaula, J. Jaén, JA. Sánchez, MJ. Ortiz. Evaluation of the utilization of external radiotherapy in the treatment of localized prostate cancer in Andalusia, Spain.. Radiation oncology (London, England). 2015 10(1): pp. 265 - 265. FI: 2.466 Q3. (doi:10.1186/s13014-015-0572-8 PMID:26715201)
  • MA. Gentil, C. Gonzalez-Corvillo, P. Castro, P. Ruiz-Esteban, C. Gracia-Guindo, T. Garcia-Alvarez, ML. Agüera, L. Ballesteros, A. Osuna, M. Alonso. Impact of Asystolic Donations in Kidney Transplant Activity From Cadaveric Donors in Andalusia.. Transplantation proceedings. 2015 47(9): pp. 2584 - 2586. FI: 0.867 Q4. (doi:10.1016/j.transproceed.2015.09.046 PMID:26680042)
  • MA. Gentil, P. Castro, L. Ballesteros, MC. Gracia-Guindo, M. Cabello, MA. Mazuecos, A. Rodriguez-Benot, C. Gonzalez-Corvillo, J. Borrego, AO. Ortega, M. Alonso. Survival of Kidney Allograft of Donors after Circulatory Death Is Similar to Donors after Brain Death: Experience in a Regional Program.. Transplantation proceedings. 2015 47(9): pp. 2572 - 2574. FI: 0.867 Q4. (doi:10.1016/j.transproceed.2015.09.045 PMID:26680038)
  • F. Navarro Freire, P. Navarro Sánchez, B. Mirón Pozo, MT. Delgado Ureña, JA. Jiménez Ríos, PA. García López, JI. Arcelus Martínez. Recurrence of liver metastases from colorectal cancer and repeat liver resection.. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2015 107(12): pp. 732 - 739. FI: 1.455 Q4. (doi:10.17235/reed.2015.3843/2015 PMID:26671585)
  • MD. Cano-Garcia, R. Casares-Perez, M. Arrabal-Martin, S. Merino-Salas, MA. Arrabal-Polo. Use of Lidocaine 2% Gel Does Not Reduce Pain during Flexible Cystoscopy and Is Not Cost-Effective.. Urology journal. 2015 12(5): pp. 2362 - 2365. FI: 0.737 Q4. ( PMID:26571322)
  • G. Perazzoli, J. Prados, R. Ortiz, O. Caba, L. Cabeza, M. Berdasco, B. Gónzalez, C. Melguizo. Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.. PloS one. 2015 10(10): pp. e0140131 - e0140131. FI: 3.057 Q1. (doi:10.1371/journal.pone.0140131 PMID:26447477)
  • C. Lepage, R. Capocaccia, M. Hackl, V. Lemmens, E. Molina, D. Pierannunzio, M. Sant, A. Trama, J. Faivre. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5.. European journal of cancer (Oxford, England : 1990). 2015 51(15): pp. 2169 - 2178. FI: 6.163 Q1. (doi:10.1016/j.ejca.2015.07.034 PMID:26421820)
  • C. Torres, A. Linares, MJ. Alejandre, RJ. Palomino-Morales, O. Caba, J. Prados, A. Aránega, JR. Delgado, A. Irigoyen, J. Martínez-Galán, FM. Ortuño, I. Rojas, S. Perales. Prognosis Relevance of Serum Cytokines in Pancreatic Cancer.. BioMed research international. 2015 2015: pp. 518284 - 518284. FI: 2.134 Q3 9. (doi:10.1155/2015/518284 PMID:26346854)
  • F. Artacho-Cordón, M. Fernández-Rodríguez, C. Garde, E. Salamanca, LM. Iribarne-Durán, P. Torné, J. Expósito, L. Papay-Ramírez, MF. Fernández, N. Olea, JP. Arrebola. Serum and adipose tissue as matrices for assessment of exposure to persistent organic pollutants in breast cancer patients.. Environmental research. 2015 142: pp. 633 - 643. FI: 3.088 Q2 2. (doi:10.1016/j.envres.2015.08.020 PMID:26318258)
  • M. Real, JM. Molina-Molina, J. Jimenez, HR. Diéguez, MF. Fernández, N. Olea. Assessment of hormone-like activities in Ginkgo biloba, Elettaria cardamomum and Plantago ovata extracts using in vitro receptor-specific bioassays.. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment. 2015 32(9): pp. 1531 - 1541. FI: 1.878 Q3. (doi:10.1080/19440049.2015.1071922 PMID:26161806)
  • R. Vera, V. Alonso, J. Gállego, E. González, C. Guillén-Ponce, C. Pericay, F. Rivera, MJ. Safont, M. Valladares-Ayerbes. Current controversies in the management of metastatic colorectal cancer.. Cancer chemotherapy and pharmacology. 2015 76(4): pp. 659 - 677. FI: 2.824 Q2 10. (doi:10.1007/s00280-015-2808-6 PMID:26113053)
  • CGP. GOMEZ-PEÑA, CLDF. DAVILA-FAJARDO, LJMG. MARTINEZ-GONZALEZ, PCS. CARMONA-SAEZ, MJSP. SOTO-PINO, JSR. SANCHEZ-RAMOS, EME. MORENO-ESCOBAR, IB. BLANCAS, JJF. FERNANDEZ, DF. FERNANDEZ, CCV. CORREA-VILCHES, JCB. CABEZA-BARRERA. Influence of the HER2 Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients: a meta-analysis. Pharmacogenetics and genomics. 2015 25(8): pp. 388 - 393. FI: 2.857 Q2. (doi:10.1097/FPC.0000000000000149 PMID:26049584)
  • P. Garcia-Alfonso, M. Chaves, A. Muñoz, A. Salud, M. García-Gonzalez, C. Grávalos, B. Massuti, E. González-Flores, B. Queralt, A. López-Ladrón, F. Losa, MJ. Gómez, A. Oltra, E. Aranda. Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study.. BMC cancer. 2015 15(1): pp. 327 - 327. FI: 3.265 Q2 8. (doi:10.1186/s12885-015-1293-y PMID:25925749)
  • J. Orgaz-Molina, M. Cotugno, MS. Girón-Prieto, MA. Arrabal-Polo, JC. Ruiz-Carrascosa, A. Buendía-Eisman, S. Arias-Santiago. A study of internet searches for medical information in dermatology patients: The patient-physician relationship.. Actas dermo-sifiliograficas. 2015 106(6): pp. 493 - 499 (doi:10.1016/j.ad.2015.01.011 PMID:25805250)
  • JP. Arrebola, H. Belhassen, F. Artacho-Cordón, R. Ghali, H. Ghorbel, H. Boussen, FM. Perez-Carrascosa, J. Expósito, A. Hedhili, N. Olea. Risk of female breast cancer and serum concentrations of organochlorine pesticides and polychlorinated biphenyls: A case-control study in Tunisia.. The Science of the total environment. 2015 520: pp. 106 - 113. FI: 3.976 Q1 4. (doi:10.1016/j.scitotenv.2015.03.045 PMID:25804877)
  • JM. Avecillas-Chasin, J. Saceda-Gutierrez, P. Alonso-Lera, R. Garcia-Pumarino, S. Issa, E. López, JA. Barcia. Scalp Metastases of Recurrent Meningiomas: Aggressive Behavior or Surgical Seeding?. World neurosurgery. 2015 84(1): pp. 121 - 131. FI: 2.685 Q2. (doi:10.1016/j.wneu.2015.02.041 PMID:25765926)
  • JP. Arrebola, MF. Fernández, P. Martin-Olmedo, JP. Bonde, JL. Martín-Rodriguez, J. Expósito, A. Rubio-Domínguez, N. Olea. Historical exposure to persistent organic pollutants and risk of incident hypertension.. Environmental research. 2015 138C: pp. 217 - 223. FI: 3.088 Q2 2. (doi:10.1016/j.envres.2015.02.018 PMID:25725302)
  • L. Cabeza, R. Ortiz, JL. Arias, J. Prados, MA. Ruiz Martínez, JM. Entrena, R. Luque, C. Melguizo. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles.. International journal of nanomedicine. 2015 10: pp. 1291 - 1306. FI: 4.32 Q1 4. (doi:10.2147/IJN.S74378 PMID:25709449)
  • I. Calvente, MF. Fernández, R. Pérez-Lobato, C. Dávila-Arias, O. Ocón, R. Ramos, S. Ríos-Arrabal, J. Villalba-Moreno, N. Olea, MI. Núñez. Outdoor characterization of radio frequency electromagnetic fields in a Spanish birth cohort.. Environmental research. 2015 138: pp. 136 - 143. FI: 3.088 Q2. (doi:10.1016/j.envres.2014.12.013 PMID:25707018)
  • M. Real, JM. Molina-Molina, I. Jiménez-Díaz, JP. Arrebola, JM. Sáenz, MF. Fernández, N. Olea. Screening of hormone-like activities in bottled waters available in Southern Spain using receptor-specific bioassays.. Environment international. 2015 74: pp. 125 - 135. FI: 5.929 Q1. (doi:10.1016/j.envint.2014.10.006 PMID:25454229)
  • C. Torres, A. Linares, MJ. Alejandre, R. Palomino-Morales, M. Martin, JR. Delgado, J. Martinez, S. Perales. The Potential Role of the Glycoprotein Osteoactivin/Glycoprotein Nonmetastatic Melanoma Protein B in Pancreatic Cancer.. Pancreas. 2015 44(2): pp. 302 - 310. FI: 2.738 Q2. (doi:10.1097/MPA.0000000000000250 PMID:25426614)
  • R. Pérez-Lobato, R. Ramos, JP. Arrebola, I. Calvente, O. Ocón-Hernández, C. Dávila-Arias, M. Pérez-García, N. Olea, MF. Fernández. Thyroid status and its association with cognitive functioning in healthy boys at 10 years of age.. European journal of endocrinology. 2015 172(2): pp. 129 - 139. FI: 3.892 Q1. (doi:10.1530/EJE-14-0093 PMID:25394567)
Última actualización de datos: 14-08-2018
27.437.579 visitas desde el 1 de Marzo de 2006
Última actualización de la pagina: 15-06-2015 Subir
Certificación Emas Certificacion Responsabilidad Social Certificacion Gestión Ambiental Certificacion Seguridad Alimentaria Certificacion Salud Laboral
Las páginas del dominio hvn.es cumplen con las normas de accesibilidad WCAG 2.0 nivel AAA
hvn.es cumple con las normas de W3C para el lenguaje de marcado XHTML 1.0
hvn.es cumple con las normas de W3C para hojas de estilo
FIBAO IBS Logo de Green Light Logo de OMARS Logo de Living Lab Salud Andalucía Red de Comités de Ética del SSPA CEI Biotic - Granada
Datos de Contacto | Webmaster | Mapa web | Nota legal | Política editorial | Uso del sitio | Accesibilidad | Preguntas frecuentas | RSS
© 2003 - 2018. Hospital Universitario Virgen de las Nieves.
- HUVN -